Home › Products › Oncology › Kabanat 60mg Injection

Kabanat 60mg Injection

Salt Composition: CABAZITAXEL

₹7890.00₹11269.41

Inclusive of all taxes

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Kabanat 60mg Injection contains cabazitaxel, an anticancer agent used together with the steroid prednisone or prednisolone to treat patients with hormone-refractory metastatic prostate cancer that has progressed following prior anticancer therapy, including docetaxel. Cancer develops from abnormal and uncontrolled cell multiplication. Early-stage prostate cancers typically require normal testosterone (male hormone) levels for growth. In hormone-refractory metastatic prostate cancer, malignant cells continue to grow despite reduction of testosterone levels in the body to low concentrations. Do not use this medicine if you have severe hepatic dysfunction or have received recent yellow fever vaccination. Major toxicities include myelosuppression, neurotoxicity, and allergic reactions. Neutropenia is the most frequently observed adverse reaction to this medication. Complete blood count monitoring is essential weekly during cycle 1 and before each subsequent treatment cycle to permit dose adjustment if required. Live attenuated vaccines should be avoided in patients receiving this medicine; inactivated or killed vaccines may be administered instead. If you are pregnant or planning pregnancy, discuss this medication with your doctor before use. This drug causes fetal harm and is contraindicated in pregnancy. Your healthcare practitioner will perform a pregnancy test prior to starting treatment. Discuss effective contraceptive methods with your doctor and use them for at least two weeks following your final dose. Avoid breastfeeding while receiving this treatment, as it is unknown whether this drug enters breast milk.

Uses

Advanced prostate cancer.

How it works

It is a mitotic inhibitor that works by disrupting the normal process of cell division. This interferes with the microtubules that help to form the cell's cytoskeleton. Microtubules are essential for the normal process of cell division, as they help to pull apart the chromosomes during mitosis. By inhibiting microtubules, this drug prevents the cancer cells from dividing properly and ultimately leads to their death.

How to Use

The medicine will be administered to you by a healthcare professional in a hospital setting. The recommended dose for this drug is 25mg, administered as an intravenous infusion over one hour every three weeks, in combination with oral prednisone (10 mg daily). The dose can be adjusted based on individual patient factors, such as age, body weight, and other medical conditions.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Low white blood cells Infection (fever, cough, muscle aches, burning on urination) Severe allergic reactions (rash, itching, breathing problems, swelling of face, chest, or throat tightness) Kidney damage Severe stomach pain Common Low red blood cell count Low blood platelet count Constipation Back pain, joint pain Decreased appetite Hair loss Numbness, burning, tingling, or decreased sensation in your feet or hands Taste change Headache, dizziness Inflammation of the mouth Blood in urine

Expert Tips

Drink at least two litres of fluids every day when you are having diarrhoea. Avoid milk, dairy products, high-fibre food or spicy food while you are having diarrhoea. Rinsing your mouth with an alcohol-free mouth gargle or salt water may help reduce the chances of infections like mouth ulcers. Risk of infection can occur as this drug can reduce the WBC count in your blood, so it is advised to avoid crowds and people who are sick and wash your hands after toileting. You must not become pregnant during treatment and must use an effective method of contraception. If pregnancy occurs during your treatment, you must inform your doctor immediately. This drug may make you dizzy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. If you are addicted to alcohol or have liver disease or epilepsy, talk to your doctor before taking this medicine.

References

  1. Annex I summary of Product Characteristics - European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/product-information/jevtana-epar-product-information_en.pdf [ Accessed on 29th March 2023]
  2. Package leaflet: Information for the user. www.hpra.ie. http://www.hpra.ie/img/uploaded/swedocuments/5a5602f0-c957-440b-b07b-fc5ca51d21ca.pdf [ Accessed on 29th March 2023]
  3. Bertram.G.Katzung, Basic and Clinical Pharmacology, Cancer Chemotherapy, 14th edition, 2017, 963.

Safety Advice

Pregnancy: unsafe It is unsafe to use during pregnancy whether Kabanat 60mg injection can be taken during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.

Lungs: Consult your doctor It is unknown whether Kabanat 60mg injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe It is unsafe to breastfeed during the treatment with this Kabanat 60mg injection because it may cause harm to the baby. Please consult your doctor before breastfeeding.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS